PATENT CLAIM ANALYSIS

Application Number: 16195794
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["546", "348000"]

Abstract:
The present invention comprises compounds of Formula I and their use in the inhibition of cell proliferation in therapeutic treatments. Pharmaceutical compositions comprising at least one compound of Formula I and at least one pharmaceutical excipient are disclosed, as well as methods of using compounds of Formula I and pharmaceutical compositions thereof for treatment of hyper-proliferative diseases and other disorders.

Claim (Index 17):
A method for treating a hyper-proliferative disease comprising the administration of the pharmaceutical composition of  claim 16  to a subject in need thereof.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 98.0
- Lexical Diversity: 1.5
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14772616', '15574800', '14654226', '12997066', '11244628']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7476087313598088
- 35 USC 102 Novelty (BERT): 0.5092857745159639
- Combined Prediction Score: 0.7237764356754243
- Mean Citation Score: 252.14883
- Max Citation Score: 314.61008
- Similarity Product: 268.14445526465414

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test